Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
109,3 USD | +2,03 % | -3,72 % | -11,16 % |
Métier
Nombre d'employés: 2 800
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4,78 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3,55 % |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12,35 % |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51,92 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Renée Galá
PSD | President | 52 | 16/03/20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29/05/19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01/11/18 |
Neena Patil
LAW | General Counsel | 49 | 01/07/19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13/05/13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01/01/09 |
Peter Gray
BRD | Director/Board Member | 69 | 08/05/13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01/01/04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01/01/10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02/05/13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27/07/12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14/02/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 62 345 283 | 60 588 007 ( 97,18 %) | 0 | 97,18 % |
Coordonnées société
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Lux SARL
Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The private company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Holdings Ltd.
|
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-11,16 % | 6,68 Md | |
+27,97 % | 676 Md | |
+23,58 % | 554 Md | |
-7,02 % | 349 Md | |
+14,85 % | 318 Md | |
+6,25 % | 291 Md | |
+2,96 % | 210 Md | |
-0,41 % | 204 Md | |
-10,02 % | 194 Md | |
-11,81 % | 144 Md |
- Bourse
- Actions
- Action JAZZ
- Société Jazz Pharmaceuticals plc